Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study
Authors:
- E. BeckEBE. Beck
- E. TestaETE. Testa
- B. LivellaraBLB. Livellara
Open Access
- 1 January 1999
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 20 (2) , 121-127
Abstract
AimsMounting evidence suggests infection, specificallyChlamydia pneumoniae,plays a role in atherosclerosis. We tested whether antibiotic treatment wiKeywords
This publication has 12 references indexed in Scilit:
- Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit modelJACC, 1998
- Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and OpportunitiesNew England Journal of Medicine, 1997
- Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot studyThe Lancet, 1997
- Epitope Specificity of Anti–Heat Shock Protein 65/60 Serum Antibodies in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Rabbit model for Chlamydia pneumoniae infectionJournal of Clinical Microbiology, 1997
- The role of infection in restenosis and atherosclerosis: focus on cytomegalovirusThe Lancet, 1996
- Epidemiology and prevention: Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in FinlandEuropean Heart Journal, 1996
- Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factorsBMJ, 1995
- Reactivation of Unstable Angina after the Discontinuation of HeparinNew England Journal of Medicine, 1992
- SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988